Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate

Richard Thomson-Luquea Centre for Infectious Diseases-Parasitology, Heidelberg University Hospital, Heidelberg, Germany;b Sumaya-Biotech GmbH & Co. KGHeidelberg, GermanyCorrespondence[email protected]

https://orcid.org/0000-0001-8378-9497 View further author information

Thomas C Stablerd Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA;f University of BaselBasel, Switzerland;g Swiss Tropical and Public Health InstituteAllschwil, SwitzerlandView further author information

Kristin Fürlea Centre for Infectious Diseases-Parasitology, Heidelberg University Hospital, Heidelberg, GermanyView further author information

Joana C Silvac Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA;d Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA;e Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa (GHTM IHMT, UNL), Lisbon, PortugalView further author information

Claudia Daubenbergerf University of BaselBasel, Switzerland;g Swiss Tropical and Public Health InstituteAllschwil, SwitzerlandCorrespondence[email protected]
View further author information

Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date